Impact of Adalimumab on Work Productivity and Activity Impairment in Japanese Patients with Rheumatoid Arthritis: Large-Scale, Prospective, Single-Cohort ANOUVEAU Study

ConclusionsTreatment with ADA provided sustained improvement in WPAI and had an acceptable safety profile in patients with RA.FundingAbbVie GK and Eisai Co., Ltd.Trial RegistrationClinicalTrials.gov identifier, NCT01346488.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research